Cases 31 - 40 of 52
Otsuka Pharmaceutical Co., Ltd. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2019cv02007
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2019cv01885
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA et al
as 1:2019cv00956
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals, Ltd. and Alembic Pharmaceuticals, Inc.
Plaintiff:
CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Alembic Pharmaceuticals, Inc. et al.
as 1:2019cv00745
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Alembic Pharmaceuticals, Inc. and Alembic Pharmacauticals, Ltd.
Cause Of Action: 35 U.S.C. § 271
Alembic Pharmaceuticals, Inc. v. Puretek Corporation
as 2:2019cv02817
Defendant:
Puretek Corporation
Plaintiff:
Alembic Pharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 44
Genentech, Inc. et al v. Alembic Pharmaceuticals, Ltd., et al
as 1:2019cv00177
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Alembic Pharmaceuticals, Ltd., Alembic Global Holding SA and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2018cv01762
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Alembic Pharmaceuticals Limited et al v. GlaxoSmithKline LLC et al
as 1:2018cv01513
Plaintiff:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Defendant:
Glaxo Group Limited and GlaxoSmithKline LLC
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Alembic Pharmaceuticals Limited, et al
as 1:2018cv00113
Plaintiff:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding S/A and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
